1.495
price up icon2.04%   0.025
 
loading

Jyong Biotech Ltd Aktie (MENS) Neueste Nachrichten

pulisher
Feb 12, 2026

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia - The Manila Times

Feb 12, 2026
pulisher
Feb 12, 2026

Prostate cancer therapy also lowers cholesterol in 2-year trial - Stock Titan

Feb 12, 2026
pulisher
Feb 10, 2026

CEO Fu-Feng Kuo, Jyong Biotech Ltd.'s (NASDAQ:MENS) largest shareholder sees value of holdings go down 23% after recent drop - Yahoo Finance

Feb 10, 2026
pulisher
Feb 06, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer - TipRanks

Feb 06, 2026
pulisher
Feb 02, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update - MarketBeat

Feb 02, 2026
pulisher
Jan 30, 2026

Jyong Biotech subsidiary announces phase II data for MCS-8 - TipRanks

Jan 30, 2026
pulisher
Jan 30, 2026

Jyong Biotech reports positive results from MCS-8 phase II trial - Investing.com

Jan 30, 2026
pulisher
Jan 30, 2026

Prostate cancer trial drug also improves cholesterol in 2-year study - stocktitan.net

Jan 30, 2026
pulisher
Jan 09, 2026

Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

Jyong Biotech Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener

Jan 09, 2026
pulisher
Jan 07, 2026

Jyong Biotech 'not aware' of any material information amid share price movement - MSN

Jan 07, 2026
pulisher
Dec 29, 2025

After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value - simplywall.st

Dec 29, 2025
pulisher
Dec 23, 2025

Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Dec 23, 2025
pulisher
Dec 22, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap UpStill a Buy? - MarketBeat

Dec 22, 2025
pulisher
Dec 21, 2025

Jyong Biotech Ltd.(NasdaqGM: MENS) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 19, 2025

Jyong Biotech addresses share price fluctuations amid lock-up expiry By Investing.com - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

Jyong Biotech in Talks With Funds Interested in Buying Shares - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

Jyong Biotech addresses share price fluctuations amid lock-up expiry - Investing.com

Dec 19, 2025
pulisher
Dec 19, 2025

Jyong Biotech in talks with investment funds for purchasing co's ordinary shares - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

Jyong Biotech ‘not aware’ of any material information amid share price movement - TipRanks

Dec 19, 2025
pulisher
Dec 19, 2025

Jyong Biotech Responds to Share Price and Volume Movement - The Manila Times

Dec 19, 2025
pulisher
Dec 18, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Dec 18, 2025
pulisher
Dec 17, 2025

Jyong Biotech (NASDAQ:MENS) Reaches New 52-Week LowHere's Why - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

Small U.S. Stocks Decrease; Jyong Biotech Falls Furthest - 富途牛牛

Dec 17, 2025
pulisher
Dec 16, 2025

Small U.S. Stocks Close Lower; Jyong Biotech Falls Furthest - 富途牛牛

Dec 16, 2025
pulisher
Dec 16, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3%Here's What Happened - MarketBeat

Dec 16, 2025
pulisher
Dec 15, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap DownWhat's Next? - MarketBeat

Dec 15, 2025
pulisher
Dec 14, 2025

Certain Ordinary Shares of Jyong Biotech Ltd. are subject to a Lock-Up Agreement Ending on 15-DEC-2025. - marketscreener.com

Dec 14, 2025
pulisher
Dec 10, 2025

Jyong Biotech Shares Becomes Oversold (MENS) - Nasdaq

Dec 10, 2025
pulisher
Dec 10, 2025

Jyong Biotech (NASDAQ:MENS) Trading Down 5.9%Here's Why - MarketBeat

Dec 10, 2025
pulisher
Dec 08, 2025

Jyong Biotech Ltd.'s (NASDAQ:MENS) Lock-Up Period Will End on December 15th - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Jyong Biotech Ltd.’s (NASDAQ:MENS) Lock-Up Period Will End on December 15th - Defense World

Dec 08, 2025
pulisher
Dec 07, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap Down – Here’s Why - Defense World

Dec 07, 2025
pulisher
Dec 06, 2025

Taiwan's Jyong Biotech expands regional partnership with MoU signing in Vietnam - BioSpectrum Asia

Dec 06, 2025
pulisher
Dec 05, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 4.3%Time to Sell? - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Jyong Biotech expands regional partnerships, signs MoU with a Vietnam pharmaceutical distributor - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor - TradingView — Track All Markets

Dec 04, 2025
pulisher
Dec 04, 2025

Jyong Biotech Expands Regional Partnerships, Signs MOU with - GlobeNewswire

Dec 04, 2025
pulisher
Dec 02, 2025

Jyong Biotech (MENS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Jyong Biotech (NASDAQ:MENS) Trading Up 15.1%Here's What Happened - MarketBeat

Dec 02, 2025
pulisher
Nov 27, 2025

Jyong Biotech: Speculative BPH And Prostate Cancer Prevention Story (NASDAQ:MENS) - Seeking Alpha

Nov 27, 2025
pulisher
Nov 26, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 9.6%What's Next? - MarketBeat

Nov 26, 2025
$26.64
price down icon 0.27%
$45.51
price up icon 1.73%
$101.92
price up icon 1.14%
$107.56
price up icon 1.82%
$150.50
price up icon 3.38%
biotechnology ONC
$350.28
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):